Enlivex ENLV Stock
Enlivex Price Chart
Enlivex ENLV Financial and Trading Overview
| Enlivex stock price | 0.69 USD |
| Previous Close | 0.73 USD |
| Open | 0.73 USD |
| Bid | 0.57 USD x 200 |
| Ask | 1.14 USD x 200 |
| Day's Range | 0.71 - 0.82 USD |
| 52 Week Range | 0.64 - 27.15 USD |
| Volume | 347.39K USD |
| Avg. Volume | 273.01K USD |
| Market Cap | 14.1M USD |
| Beta (5Y Monthly) | 1.416 |
| PE Ratio (TTM) | 0.0021104133 |
| EPS (TTM) | 382.2 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 80 USD |
ENLV Valuation Measures
| Enterprise Value | 7.65M USD |
| Trailing P/E | 0.0021104133 |
| Forward P/E | -1.0341026 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.0065969834 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.522 |
Trading Information
Enlivex Stock Price History
| Beta (5Y Monthly) | 1.416 |
| 52-Week Change | -94.90% |
| S&P500 52-Week Change | 14.29% |
| 52 Week High | 27.15 USD |
| 52 Week Low | 0.64 USD |
| 50-Day Moving Average | 2.38 USD |
| 200-Day Moving Average | 10.65 USD |
ENLV Share Statistics
| Avg. Volume (3 month) | 273.01K USD |
| Avg. Daily Volume (10-Days) | 330.83K USD |
| Shares Outstanding | 17.49M |
| Float | 4.82M |
| Short Ratio | 0.4 |
| % Held by Insiders | 78.36% |
| % Held by Institutions | 1.61% |
| Shares Short | 119.85K |
| Short % of Float | 0.68% |
| Short % of Shares Outstanding | 0.68% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -0.79% |
| Return on Equity (ttm) | 126.16% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -14668000 USD |
| Net Income Avi to Common (ttm) | 1.24B USD |
| Diluted EPS (ttm) | 382.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.76M USD |
| Total Cash Per Share (mrq) | 0.36 USD |
| Total Debt (mrq) | 641K USD |
| Total Debt/Equity (mrq) | 0.03 USD |
| Current Ratio (mrq) | 193.236 |
| Book Value Per Share (mrq) | 122.268 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10416000 USD |
| Levered Free Cash Flow (ttm) | -1737054976 USD |
Profile of Enlivex
| Country | United States |
| State | N/A |
| City | Ness Ziona |
| Address | 14 Einstein Street |
| ZIP | 7403618 |
| Phone | 972 2 620 8072 |
| Website | https://www.enlivex.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 34 |
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
Q&A For Enlivex Stock
What is a current ENLV stock price?
Enlivex ENLV stock price today per share is 0.69 USD.
How to purchase Enlivex stock?
You can buy ENLV shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enlivex?
The stock symbol or ticker of Enlivex is ENLV.
Which industry does the Enlivex company belong to?
The Enlivex industry is Biotechnology.
How many shares does Enlivex have in circulation?
The max supply of Enlivex shares is 17.49M.
What is Enlivex Price to Earnings Ratio (PE Ratio)?
Enlivex PE Ratio is 0.00181266 now.
What was Enlivex earnings per share over the trailing 12 months (TTM)?
Enlivex EPS is 382.2 USD over the trailing 12 months.
Which sector does the Enlivex company belong to?
The Enlivex sector is Healthcare.
Enlivex ENLV included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27122.09 USD — |
+2.26
|
7.86B USD — | 26707.42 USD — | 27183.93 USD — | — - | 7.86B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
138.89 USD — |
+1.08
|
— — | 138.62 USD — | 139.38 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1323.55 USD — |
+0.88
|
— — | 1309.56 USD — | 1327.32 USD — | — - | — — |
- {{ link.label }} {{link}}
